Abstract C135: Therapeutic targets for MYC-driven cancer.
Masafumi Toyoshima(Nippon Medical School Hospital), Carla Grandori(Precision for Medicine (United States)), Ryan Walsh(Texas Neurology), Julie Park(University of California, Los Angeles), Heather L. Howie(Bloodworks Northwest), Maki Imakura
Cited by 0
Related Papers
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
|Proceedings of the National Academy of Sciences|2000|827
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
|Nature Cell Biology|2005|671